A Phase 1-1b Study to Evaluate the Safety, Efficacy and Dosimetry of Study Drug A9-3408 in Subjects With Metastatic Melanoma

Clinical trial NCT07076550 · RECRUITING

Trial details

NCT number: NCT07076550
Sponsor: Alpha-9 Oncology USA Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Melanoma Metastatic Uveal Melanoma, Metastatic Mucosal Melanoma

Start date: 2025-11-19
Primary completion: 2028-01-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.